Company Name: Versartis, Inc.   

Versartis, Inc. is a biopharmaceutical company. The company is engaged in the development of long-acting therapeutic proteins designed to treat endocrine disorders. The company’s initial developmental product candidate is designed to treat growth hormone deficiency (GHD).

Ticker Symbol: VSAR (NASDAQ)

Company Website: www.versartis.com

Social Media: Versartis LinkedIn

Headquarters: Menlo Park, California